News
As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: ...
This work shows how AI can help speed up and lower the cost of developing proteins used in medicine. For drug and biotech ...
(NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company focused on developing targeted ...
RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to ...
We are in an age where medicine is no longer one-size-fits-all; personalised healthcare is changing the diagnosis and ...
America’s lead here is narrower: it is ahead in chip design but East Asia remains the industrial centre of gravity. China, ...
The government says every corner of the country will benefit, but research backers call for a long-term plan for science.
3don MSN
“The multicellular nature of a plant – their roots, tissues, vegetative and reproductive organs- makes it a complex challenge ...
The great outdoors is often where engaged couples find their ideal wedding setting. Some especially have their hearts set on ...
The Gates Foundation has awarded Evaxion A/S (NASDAQ:EVAX) a grant to use its exclusive AI-Immunology™ technology to develop ...
The Radford University Board of Supervisors worked together to unanimously approve a proposal to create a new undergraduate ...
A new project, co-led by Dr Joshua James and Professor Patrick Cai of the Manchester Institute of Biotechnology at The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results